Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T06:37:39.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information related to Non-Small Cell Lung Cancer (NSCLC) treatments, specifically mentioning Carboplatin, Cisplatin, Tiragolumab, and Pembrolizumab, while significant details about the study's purpose and criteria have been removed.
    Difference
    13%
    Check dated 2025-04-16T21:59:31.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added indicating March 7, 2025. However, there are no significant changes in core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-04-09T16:58:05.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 7, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-02T01:27:56.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a reduction in the number of study locations from 140 to 128, with several specific locations in the United States and Brazil being added or removed. Additionally, there are updates to the dates related to the study's timeline.
    Difference
    24%
    Check dated 2025-03-11T09:41:28.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-25T00:31:25.000Z thumbnail image

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.